ALTERITY THERAP.ADR/600

ALTERITY THERAP.ADR/600

Depository Receipt · US02155X2053 · ATHE · A3D4GD (XNCM)
Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of ALTERITY THERAP.ADR/600
No Price
29.04.2026 13:31
Current Prices from ALTERITY THERAP.ADR/600
ExchangeTickerCurrencyLast TradePriceDaily Change
XNAS: NASDAQ
NASDAQ
ATHE
USD
29.04.2026 13:31
4,65 USD
0,07 USD
+1,50 %
IEXG: IEX
IEX
ATHE
USD
28.04.2026 17:26
4,58 USD
-0,04 USD
-0,87 %
Company Profile for ALTERITY THERAP.ADR/600 Depository Receipt
Alterity Therapeutics Limited engages in the research and development of therapeutic drugs to treat Alzheimer's disease, Huntington disease, Parkinson's disease, and other neurological disorders in Australia. The company's lead drug candidate is ATH434 that has completed Phase I clinical trial for the treatment of Parkinson's disease. It is also developing PBT2 that has completed Phase IIa clinical trial to treat Alzheimer's disease. The company was formerly known as Prana Biotechnology Limited and changed its name to Alterity Therapeutics Limited in April 2019. Alterity Therapeutics Limited was incorporated in 1997 and is headquartered in Melbourne, Australia.

Company Data

Name ALTERITY THERAP.ADR/600
Company Alterity Therapeutics Limited
Symbol ATHE
Website https://alteritytherapeutics.com
Primary Exchange XNCM Frankfurt
WKN A3D4GD
ISIN US02155X2053
Asset Class Depository Receipt
Sector Healthcare
Industry Biotechnology
CEO David A. Stamler
Market Capitalization 42 Mio
Country Australia
Currency EUR
Employees 0,0 T
Address 460 Bourke Street, 3000 Melbourne
IPO Date 2003-09-29

Stock Splits

Date Split
09.01.2023 1:10
24.03.2016 1:6

ID Changes

Date From To
09.04.2019 PRAN ATHE

Ticker Symbols

Name Symbol
Frankfurt PBN0.F
NASDAQ ATHE
More Shares
Investors who hold ALTERITY THERAP.ADR/600 also have the following shares in their portfolio:
KRANESHARES CICC CHINA LEADERS 100 INDEX ETF
KRANESHARES CICC CHINA LEADERS 100 INDEX ETF ETF
SANDWELL COMMERCIAL FINANCE NO.1 PLC C MTGE BCKD FRN 11/05/39 £(BR)(REG S)
SANDWELL COMMERCIAL FINANCE NO.1 PLC C MTGE BCKD FRN 11/05/39 £(BR)(REG S) Bond